Dear SOT Members,
Below are a number of SOT-sponsored meetings and events that may be of interest to you. For more information, contact the organizers directly.
Dose Response Assessment Boot Camp—May 6–10, 2013
A Dose Reponse Assessment Boot Camp will be held May 6–10, in Cincinnati, Ohio. This training opportunity is for individuals in the risk assessment or toxicology field. The course is a 5‐day intensive hands‐on training in hazard characterization and dose response assessment. Beginners through expert toxicological risk assessors will learn advanced methods, as well as enhance their understanding and skills in the basics. Course lectures will be supplemented with daily hands–on application exercises. Upon completion of the course, participants will be able to derive and evaluate risk values and supporting documentation for both noncancer and cancer risk assessments. Five Continuing Maintenance (CM) points will be available from the American Board of Industrial Hygienists (ABIH). For additional information, please visit the workshop website.
Moving Forward in Human Risk Assessment in the Genomics Era 2.0—May 16–17, 2013
A workshop, "Moving Forward in Human Risk Assessment in the Genomics Era 2.0," will be held on May 16–17, 2013, at the OECD Congress Center, Paris, France. This workshop will be held with the goal to review progress in human carcinogenesis safety evaluation strategies and cancer risk assessment. Experts and opinion leaders from academia, industry, and regulatory agencies in the US, EU, and Asia, will convene to discuss the utility of exploiting genomics approaches in understanding genotoxicity findings and in chemical carcinogenicity risk assessment, as well as the informatics needs to support optimal access and use of these data. Novel assay development and promising emerging data mining and modeling approaches will be discussed with particular emphasis on identifying gaps and opportunities for their application in human cancer risk assessment. This is a follow-up to a workshop held in Venice in August 2009. For additional information, please visit the workshop website.
New York Academy: Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment—May 29–31, 2013
The "Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment" conference will be held May 29–31, 2013, at the New York Academy of Sciences in New York City. To date, two separate groups have been studying bone marrow: toxicologists who examine chemically-induced marrow pathologies and hematologists/oncologists who investigate diseases of the marrow. This conference will bring together representatives from both fields around a jointly shared goal—to better understand, prevent, and treat myeloid malignancies. Conference sessions will combine basic science and toxicology research at the level of the bone marrow niche with clinical findings from healthy subjects and patients. Topics include the bone marrow niche structure and function, the maturation and differentiation of healthy and leukemogenic hematopoietic stem cells, cutting-edge models and tools for research, and the environmental, chemical, and genetic factors involved in the development of myeloid abnormalities, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The meeting will feature a series of plenary lectures, panel discussions, a poster session, and short talk presentations by early career investigators. A complete agenda and registration information is available on The New York Academy of Sciences website.
Environmental Mutagenesis and Genomics Society 44th Annual Meeting—Abstract Deadline June 1, 2013
The 44th Annual Meeting of the Environmental Mutagenesis and Genomics Society (EMGS), will be held September 21–25, 2013, at the Hyatt Regency Monterey, in Monterey, California. This year's theme is “Embracing the Science of the Future through Cross-Disciplinary Research.” The meeting provides a broad scientific forum for basic and applied researchers as well as students and teachers to review the latest information linking environmental conditions to adverse health outcomes. The emphasis of the meeting is to (i) to build on our past contributions to the field of environmental and molecular mutagenesis and DNA repair and more fully understand the role of epigenetics in these basic mechanisms; (ii) to integrate applied genetic toxicology with basic research in DNA damage and repair, toxicogenomics, and epigenetics; (iii) to determine how interdisciplinary information can be best used to direct translational human epidemiological studies; (iv) to have these data serve as a foundation for human risk assessment for disease and disease prevention; and finally (v) to aid in the support of knowledge-based regulation to protect public health and the environment. The abstract deadline is June 1, 2013. For additional information, please visit the EMGS 44th Annual Meeting website.
Society of Toxicologic Pathology 32nd Annual Symposium—June 16–20, 2013
The Society of Toxicologic Pathology (STP) 32nd Annual Symposium, “Toxicologic Pathology of the Digestive Tract and Pancreas,” will take place June 16–20 at the Oregon Convention Center in Portland, Oregon. The 2013 STP Scientific Symposium will cover fundamental biology and recent innovations in the toxicologic pathology of the digestive tract and pancreas. The focus of this international meeting is to correlate advances in the morphologic evaluation and integration of findings in the digestive tract and pancreas with functional, cellular, and molecular knowledge in a series of plenary and poster sessions. The meeting will provide a venue for interactive discussion of the current state of knowledge in both conventional and specialized nonclinical safety studies of the digestive tract and pancreas. Program information is available on the STP 32nd Annual Symposium website.
Teratology Society 53rd Annual Meeting—June 22–26, 2013
The 53rd Annual Meeting of the Teratology Society will be held June 22–26, 2013, in Tucson, Arizona. The theme of the 2013 meeting is "Application of Cutting-Edge Technologies to Improve Assessment, Treatment, Prevention, and Communication regarding Birth Defects." Sessions will highlight teratology research and issues that have global impact, with topics including advances in genomic sciences, application of imaging technologies, predictive developmental toxicology, diabetes and pregnancy, and chemotherapeutics. The interdisciplinary nature of the Society provides unique opportunities to look broadly at these complex issues. For more information, visit the Teratology Society 53rd Annual Meeting website.
Society of Toxicologic Pathology Modular Education Series Inaugural Course: Neuropathology—July 21–24, 2013
The Society of Toxicologic Pathology (STP) is offering "Neuropathology," the inaugural course in the Modular Education Series, July 21–24, 2013, at the Chauncey Conference Center in Princeton, New Jersey. The course is planned in partnership with the British Society of Toxicological Pathology and with help from the STP Special Interest Group in Neuropathology. The course will include both didactic lectures and practical data and slide review sessions. Microscopic evaluation of histologic sections will be done using whole-slide digital pathology images and practical evaluation/interpretation of toxicologic pathology data will be emphasized. The modular course series is designed primarily for novice practitioners of toxicologic pathology. However, pathology residents with an interest in this specialty or experienced pathologists who desire a refresher course are welcome. In addition, nonpathologists with an interest in the normal histology, pathology, or toxicology of the nervous system also will benefit from this module. For course details and registration, please visit the STP website.
Cellular & Molecular Mechanisms of Toxicity Gordon Research Conference: August 11–16, 2013
The Cellular & Molecular Mechanisms of Toxicity Gordon Research Conference will be held August 11–16, 2013, in Andover, New Hampshire. This conference is a premier forum for showcasing the latest, most innovative advances in mechanistic toxicological research. For the 2013 conference, the organizers have assembled a group of world-leading experts working on areas of investigation that are highly relevant to environmental, industrial, and pharmaceutical toxicology. The topics selected are varied and of great appeal to a broad audience of scientists with an interest in toxicology. Mitochondrial diseases, epigenetics, transcriptional control of drug metabolizing enzymes, carcinogenesis, stem cells in toxicological research and novel functions of oxidative stress-related transcription factors are among the topics that will be highlighted at the conference. Applications for this meeting must be submitted by July 14, 2013. For more information, visit the Cellular & Molecluar Mechanisms of Toxicity Conference website.
Safety Pharmacology Society Annual Meeting, September 16–19, 2013
The Safety Pharmacology Society (SPS) 13th Annual Meeting will be held September 16–19, 2013, in Rotterdam, the Netherlands, and will provide a dynamic forum for sharing the latest in safety pharmacology. The scientific program offers in-depth discussion of relevant topics to keep you “in the know.” This meeting will feature a diverse range of scientific sessions organized into thematic tracks, covering issues such as, Reducing Safety Related Attrition, Expanding the Frontiers of Safety Pharmacology, Improving Support to Clinical Development, Translation of Safety Pharmacology Studies to Humans, and a Best Practices Workshop on Comparing Safety Pharmacology as “Stand Alone” to SP-Endpoint Inclusion in Toxicology. The meeting also will offer a full day of Continuing Education courses both on an introductory level as well as advanced courses for the expert. For preliminary meeting information, please visit the SPS 13th Annual Meeting website.
FutureToxII CCT: Pathways to Perdiction—January 16–17, 2014
The FutureToxII: In Vitro Data and In Silico Models for Predictive Toxicology Contemporary Concepts in Toxicology (CCT) conference wil be held January 16–17, 2014, at the William and Ida Friday Center for Continuing Education, University of North Carolina, Chapel Hill, North Carolina. The conference aims to address the pathway-based strategy by bringing together basic research into a CCT that integrates newer in vitro methodologies and computational (in silico) modeling approaches with advances in systems biology. An overarching goal is to clarify the usefulness and validity of new and emerging technologies and approaches, so that expectations can be managed in both the regulatory and regulated scientific communities. Some aspects of this topic were covered in the October 2012 FutureTox CCT. The FutureToxII CCT will provide a forum for a detailed, scientific discussion of how the biological pathways of interest will be elucidated, characterized, and qualified for pathway-based risk assessment. Breakout groups will address four key areas: Regulatory Toxicology, Liver Disease and Hepatotoxicity, Developmental/ Reproductive Toxicity, and Cancer. There is global interest in “Adverse Outcome Pathways” (AOPs) as a conceptual framework for mode-of-action approaches in these four areas. As such, focusing the CCT on scientific issues where new methodologies and advances can move us beyond reliance on animal models will benefit all researchers and regulators as a way of identifying key questions that need research. For additional information and to register, please visit the FutureToxII website.
SOT sponsors two types of meetings outside of the SOT Annual Meeting: Contemporary Concepts in Toxicology (CCT) and Non-SOT meetings. CCT meetings are one- to two-day focused, open registration, scientific meetings in contemporary and rapidly progressing areas of toxicological sciences. Non-SOT meetings are sponsored by other not-for-profit organizations and SOT will either endorse or provide sponsorship money to toxicology-related meetings.